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Abstract
Background: Atherosclerosis is a chronic inflammatory disease of artery wall characterized by infiltration of
monocytes into subendothelial space and their differentiation into macrophages. Since rupture-prone plaques
commonly contain high amounts of activated macrophages, imaging of the macrophage content may provide a
useful tool for the evaluation of plaque vulnerability. The purpose of this study was to explore the uptake of
68gallium (
68Ga) in atherosclerotic plaques in mice.
Methods: Uptake of ionic
68Ga was investigated in atherosclerotic LDLR
-/-ApoB
100/100 and C57BL/6N control mice
at 3 h after injection. The ex vivo biodistribution of the
68Ga was assessed and autoradiography of aortic
cryosections was defined. In vivo imaging of
68Ga was performed using a small animal positron emission
tomography PET/CT scanner.
Results: Our results revealed that the uptake of
68Ga-radioactivity was higher in atherosclerotic plaques than in
healthy vessel wall (ratio 1.8 ± 0.2, p = 0.0002) and adventitia (ratio 1.3 ± 0.2, p = 0.0011). The autoradiography
signal co-localized with macrophages prominently as demonstrated by Mac-3 staining. In both mice strains, the
highest level of radioactivity was found in the blood.
Conclusions: We observed a moderate but significantly elevated
68Ga-radioactivity uptake in the aortic plaques of
atherosclerotic mice, especially at the sites rich in macrophages. While the uptake of
68Ga was promising in this
animal model, the slow blood clearance may limit the usability of
68Ga as a PET tracer for clinical imaging of
atherosclerotic plaques.
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Background
Atherosclerosis is a chronic inflammatory disease of
artery wall with infiltration of monocytes into suben-
dothelial space and their differentiation into macro-
phages. Macrophages express pro-inflammatory and
chemotactic molecules thus playing an essential role in
the formation, progression, and pathogenicity of athero-
sclerotic plaques. The population of macrophages in
atherosclerotic lesions is heterogeneous. The majority of
macrophages transform into foam cells by accumulating
lipids in their cytoplasm, while other macrophages may
have vascular protective and repair properties.
Furthermore, some macrophages may secrete enzymes
that degrade the extracellular matrix and fibrous cap,
possibly leading to a rupture of the atherosclerotic pla-
que. Significantly higher quantities of macrophage-rich
plaque areas have been reported in atherosclerotic
patients with acute coronary syndromes than in patients
with stable angina. Since the rupture-prone plaques
commonly contain high amounts of activated macro-
phages, imaging of the macrophages may provide a use-
ful tool for determining plaque vulnerability [1-5].
68Gallium (
68Ga, T1/2 68 min) is a generator-produced,
positron-emitting radionuclide with a high positron yield
(89%) possessing suitable physical properties for in vivo
PET imaging.
67Gallium (
67Ga) has traditionally been used
to image inflammation with gamma cameras. Since
68Ga
owns the same chemical characteristics as
67Ga, it is
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68Ga could accumulate at the sites of
macrophage-rich areas in inflammatory lesions. Further-
more,
68Ga-based PET may have some added advantages
compared to
67Ga-based SPECT, such as a better resolu-
tion for the detection of inflammatory plaques [6]. The
aim of this study was to determine the uptake of ionic
68Ga in the atherosclerotic plaques in mice.
Methods
Production of ionic
68Ga
68Ga radionuclide is readily available by elution from a
68Ge/
68Ga generator (Cyclotron Co., Obninsk, Russia)
with 0.1 M HCl. The radioactive elution peak, moni-
tored online with a positron-sensitive photodiode detec-
tor (Hamamatsu S5591, Hamamatsu Photonics K.K.
Solid State Division, Hamatsu City, Japan), was collected
and the
68Ga-chloride was neutralized with 1 M NaOH
to give pH value of 7, as described earlier [7]. The quan-
tity of colloidal
68Ga in the final product was measured
by ultrafiltration, as indicated by the activity retained on
the 0.2- μm ultrafilter. The final
68Ga product contained
13% of colloidal forms of
68Ga.
Ex vivo biodistribution of
68Ga
Nine 10-11-months-old male atherosclerotic LDLR
-/-
ApoB
100/100 mice (weight 35 ± 5 g, mean ± SD) [8,9]
and six 2.5-month-old male non-atherosclerotic C57BL/
6N control mice (weight 28 ± 1 g) were ex vivo investi-
gated. LDLR
-/-ApoB
100/100 mice were kept on a high-fat,
Western-type diet (TD 88173, Harlan Teklad) for 3-4
months, starting at 7 months of age. C57BL/6N mice
were fed with regular diet. The experiments were
approved by the Laboratory Animal Care and Use Com-
mittee of the University of Turku, Finland.
68Ga (17 ± 2 MBq) was intravenously administered via
a tail vein in non-anesthetized mice. Three hours after
injection the mice were sacrificed under deep isoflurane
anesthesia by cervical dislocation. Samples of blood and
various tissues were excised, patted dry, weighed, and
measured for radioactivity using an automatic gamma
counter (1480 Wizard 3” Gamma Counter; EG & G
Wallac, Turku, Finland) cross-calibrated with a dose
calibrator (VDC-202, Veenstra Instruments, Joure, The
Netherlands). The radioactivity remaining in the tail was
compensated, background counts were subtracted, and
the radioactivity decay was corrected to the time of
injection. The concentration of the radioactivity accu-
mulated in the various tissues over the 3-h period fol-
lowing
68Ga injection was expressed as a percentage of
the injected activity per gram of tissue (% IA/g).
Autoradiography analysis of aortic cryosections
The distribution of
68Ga-radioactivity in the aortic tissue
was studied by combining digital autoradiography and
hematoxylin and eosin (HE) staining. The aorta and
internal control muscle sample from the same animal
were frozen and sequential longitudinal 8- and 20- μm
sections were cut with a cryomicrotome at -15°C, thaw-
mounted onto microscope slides. The sections were air
dried for 5 min and apposed to an imaging plate (Fuji
Imaging Plate BAS-TR2025, Fuji Photo Film Co., Ltd.,
Japan). After an exposure time of 2.5 h, the imaging
plates were scanned with Fuji Analyser BAS-5000 (Fuji
Tokyo, Japan; internal resolution 25 μm). The 20- μm
cryosections were stained with HE and examined for
morphology under a light microscope. After carefully
co-registration of the autoradiographs and HE images,
68Ga-radioactivities were measured in the following
regions of interest (ROIs): (1) plaque (excluding media),
(2) healthy vessel wall (no lesion formation), (3) adventi-
tia (including adjacent fat), and (4) muscle (internal con-
trol tissue). In control mice, no plaque areas were seen
and ROIs were defined for healthy vessel wall, adventi-
tia, and muscle. In each mouse, the uptakes of
68Ga-
radioactivities in the regions of interest were calculated
and normalized against internal control tissue (muscle).
The results of digital autoradiography analysis were
expressed as photostimulated luminescence per square
millimeter (PSL/mm
2).
Assessment of degree of inflammation in atherosclerotic
plaques
Immunohistochemical staining with the mouse macro-
phage specific antibody (Mac-3, clone m3/84, BD Phar-
mingen, BD550292, USA - BD Biosciences Pharmingen,
Franklin Lakes, NJ, USA) was performed using aortic
longitudinal 8- μm cryosections in order to detect acti-
v a t e dm a c r o p h a g e s ,a sd e s c r i b e de a r l i e r[ 1 0 ] .B a s e do n
the Mac-3 staining, plaque areas were divided into four
categories for the semiquantitative estimation of the
degree of plaque inflammation; (1) no inflammation =
no macrophages, (2) mild inflammation = occasional
macrophages, (3) moderate inflammation = occasional
and some groups of macrophages, (4) severe inflamma-
tion = abundant infiltration of macrophages. The uptake
of
68Ga-radioactivity in the different categories was stu-
died with digital autoradiography from 8- μm cryosec-
tions combined with images of Mac-3 immunostained
sections. The results of digital autoradiography analysis
were normalized against internal control tissue (muscle)
and expressed as PSL/mm
2.
In vivo imaging
Three additional female LDLR
-/-ApoB
100/100 mice, aged
14 to 15 months and kept on a high-fat, Western-type
diet for 5 to 6 months (weight 36 ± 10 g, mean ± SD)
were in vivo imaged with the Inveon small animal
PET/CT scanner (Siemens Medical Solutions,
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68Ga (16
± 3 MBq). PET images were acquired for 15 min, fol-
lowed by CT angiography (10 min) without moving
the animal. To obtain vascular contrast, 0.2 ml of iodi-
nated intravascular contrast agent eXIATM160XL
(Binitio Biomedical Inc, Ottawa, ON, Canada) was
injected. CT acquisition consisted of 270 projections
acquired with exposure time of 400 ms, x-ray voltage
of 80 kVp, and anode current of 400 μA for a full 360°
rotation. Mice were kept fully sedated with 1.5% iso-
flurane during imaging. PET image was reconstructed
using OSEM3D algorithm. The resulting matrix was
128 × 128 pixels with 159 transverse slices in a trans-
axial field of view of 12.7 cm (pixel size 0.87 × 0.87 ×
0.80 mm). CT image was reconstructed using a modi-
fied Feldkamp algorithm. The resulting matrix was 256
× 256 pixels with 384 transverse slices (pixel size 0.17
× 0.17 × 0.17 mm). Co-registration of PET and CT
images was done using an automatic weighted mutual
information algorithm and confirmed visually on the
basis of anatomical landmarks. Quantitative PET analy-
s i sw a sp e r f o r m e db yd r a w i n gR O I so ft h es a m es i z ei n
the left ventricle (blood pool), aortic arch, and brachio-
cephalic artery as identified on the basis of the CT
angiography by using the Inveon Research Workplace
software (Siemens Medical Solutions, Knoxville, TN,
USA). Radioactivity concentrations were corrected for
injected radioactivity, and the results were expressed as
percentage of injected radioactivity per gram of tissue
(% IA/g) assuming 1 mL equals 1 g.
Statistical methods
All the results are expressed as mean ± SD. Student’s t-
test and one-way ANOVA were applied when compar-
ing the biodistribution results of the atherosclerotic and
control mice. T test with a mixed Dunnett’sm o d e lw a s
used to correct the p values of biodistribution of aortic
uptake versus different tissue uptakes in the athero-
sclerotic and control mice groups. In the autoradio-
graphic analysis, a mixed model with Tukey-Kramer
corrected p values was applied to individual mean values
of ROIs. A p value less than 0.05 was considered as sta-
tistically significant.
Results
Characterization of atherosclerotic plaques
After 3 to 4 months on a Western-type diet, the LDLR
-/-
ApoB
100/100 mice had developed areas covered with
atherosclerotic plaques in aortic arch, aortic arteries,
and also in the distal part of aorta. Histologically, the
plaques were of fibroatheroma type and some of them
contained calcifications. In the aortas of the control
mice, no atherosclerotic plaques were detected.
Ex vivo biodistribution of
68Ga-radioactivity
The biodistribution of
68Ga-radioactivity at 3 h after i.v.
injection is shown in Table 1. The highest level of
68Ga-
radioactivity was found in the blood in both mouse
s t r a i n s .T h eu p t a k ei nt h ew h o l ea o r t aw a sh i g h e ri n
LDLR
-/-ApoB
100/100 mice than in control mice, but the
difference did not reach statistical significance. The
aorta/heart and aorta/blood uptake ratios were 1.6 ± 0.7
and 0.2 ± 0.1 in atherosclerotic mice and 1.2 ± 0.2 and
0.2 ± 0.1 in control mice, respectively. The measured
radioactivities in the bone and liver of atherosclerotic
mice were significantly lower than in the control mice.
Digital autoradiography of aortic cryosections
A total of 8 to 12 autoradiographs of aortic cryosections
from eight LDLR
-/-ApoB
100/100 mice (one sample was
discarded from the analysis because of remaining blood
clot inside the aorta) and 8 autoradiographs of aortic
sections from six control mice were generated and
superimposed on corresponding digitalized HE staining
images. In total, 1,208 ROIs (plaque n =3 8 4 ,h e a l t h y
vessel wall n = 396, adventitia n =4 0 6 ,m u s c l en =5 6 )
were analyzed from 14 mice. The autoradiography ana-
lysis revealed a significantly higher uptake of
68Ga-radio-
activity in plaques compared with healthy vessel wall
(3.4 ± 0.6 vs. 1.9 ± 0.3 PSL/mm
2, p = 0.0002) and
adventitia (3.4 ± 0.6 vs. 2.6 ± 0.3 PSL/mm
2, p = 0.0011).
The plaque/wall ratio was 1.8 ± 0.2 and plaque/adventi-
tia ratio 1.3 ± 0.2 in LDLR
-/-ApoB
100/100 mice (Figure 1).
T h ed i f f e r e n c eb e t w e e nt h ea d v e n t i t i aa n dt h eh e a l t h y
Table 1 Ex vivo biodistribution of radioactivity in
atherosclerotic LDLR
-/-ApoB
100/100 and C57BL/6N control
mice
LDLR
-/-/ApoB
100/100
(n = 9, urine n =8 )
C57BL/6N
(n = 6, urine n =5 )
p value
Aorta 1.99 ± 0.73 1.52 ± 0.40 NS
a
Bladder 2.50 ± 0.62 1.92 ± 0.29 NS
Blood 8.60 ± 1.29 8.07 ± 0.55 NS
Bone 2.25 ± 0.50 4.08 ± 0.49 < 0.05
Fat 0.46 ± 0.21 0.51 ± 0.07 NS
Heart 1.26 ± 0.26 1.29 ± 0.20 NS
Intestine 2.71 ± 0.70 3.16 ± 0.36 NS
Kidney 4.07 ± 0.78 4.25 ± 0.33 NS
Liver 2.69 ± 1.14 8.34 ± 4.33 < 0.05
Lungs 3.28 ± 1.10 3.58 ± 0.33 NS
Lymph nodes 2.03 ± 0.51 2.35 ± 0.34 NS
Muscle 0.71 ± 0.24 0.71 ± 0.08 NS
Pancreas 1.21 ± 0.25 1.48 ± 0.21 NS
Spleen 3.20 ± 1.28 4.51 ± 1.63 NS
Thymus 1.89 ± 0.96 1.18 ± 0.15 NS
At 3 h after intravenous injection of ionic
68Ga. Results are expressed as % IA/
g (mean ± SD). NS, not significant.
aDifference between atherosclerotic and
control mice.
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the mouse strains. A relatively high uptake of
68Ga-
radioactivity was detected in the calcified areas (n =5 5
from the total 384 plaque ROIs) of atherosclerotic pla-
ques vs. healthy vessel wall (ratio 2.1 ± 0.6, p = 0.0010).
Calcified areas did not contain any macrophages. No
statistically significant difference was detected in calci-
fied areas of plaques vs. non-calcified plaques. The
variability of the used digital autoradiography analysis
has been tested and described earlier [10].
Assessment of
68Ga-radioactivity uptake in macrophage-
rich areas of atherosclerotic plaques
A total of 184 plaques obtained from four aortic cryo-
sections of each LDLR
-/-ApoB
100/100 m o u s ew e r ea n a -
lyzed and normalized against internal control tissue
(muscle). According to the autoradiographic analysis,
the uptake of
68Ga in plaques with different degrees of
inflammation was 1.5 ± 0.7 PSL/mm
2 in non-inflamed
plaques (n = 16), 2.3 ± 0.8 PSL/mm
2 in mildly
inflamed plaques (n = 38), 3.6 ± 1.5 PSL/mm
2 in mod-
erately inflamed plaques (n = 89), and 4.3 ± 1.9 PSL/
mm
2 in severely inflamed plaques (n = 41). Figure 2
shows the co-localisation of the
68Ga-radioactivity
uptake and degree of macrophage-rich areas in athero-
sclerotic plaques. Representative Mac-3 stainings of
non-inflamed and severely inflamed plaques are shown
in Figure 3.
In vivo imaging
In vivo PET/CT imaging demonstrated high radioactivity
in the blood pool (8.1 ± 2.2% IA/g, n =3 )a t3ha f t e r
68Ga injection as seen in the aorta and heart of LDLR
-/-
ApoB
100/100 mouse (Figure 4). The in vivo uptake of
Figure 1 An example of ex vivo aortic autoradiographic (ARG) analysis.( A) HE staining of a 20-μm cryosection, showing the aortic arch and
branches of arteries (B) autoradiograph (grayscale) from section (A) superimposed with the patch image made from the HE-stained section (A).
(C) Autoradiograph superimposed with contour image and an example of ROI analysis: R2 and R4, plaque; R1 and R3, healthy vessel wall; R5 and
R6, adventitia. (D) Panel shows the ARG results of section (C). Results are expressed as PSL/mm
2 (mean ± SD), normalized against the internal
control tissue (muscle). In this representative section, the plaque/wall ratio is 1.6 and plaque/adventitia ratio 1.1, whereas in the whole study
population, the corresponding ratios were 1.8 ± 0.2 and 1.3 ± 0.2.
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artery was 6.4 ± 3.0 and 5.8 ± 2.5% IA/g, respectively.
Discussion
Macrophages play a crucial role in the progression and
development of atherosclerosis from early fatty-streak
lesions to advanced atherosclerotic plaques [11]. Rup-
tured plaques, in particular, commonly contain high
quantities of macrophages [3]. Therefore, the contents
of macrophages may be an excellent imaging biomarker
for the vulnerability of atherosclerotic plaques. The pre-
sent results revealed that the
68Ga-radioactivity uptake
in atherosclerotic plaques, especially in their macro-
phage-rich areas, was higher when compared to healthy
vessel wall. This observation strengthens our conception
that
68Ga-radioactivity accumulates at the site of
inflammation.
68Ga radionuclide is readily available by elution from a
68Ge/
68Ga generator with 0.1 M HCl in the form of
68Ga-chloride. However, after neutralization,
68Ga-chlor-
ide is hydrolyzed in situ or after administration in vivo.
In general, ionic
68Ga
3+ is in the form of soluble anion
called gallate,
68Ga(OH)
-
4, and/or insoluble colloidal
particles
68Ga(OH)3. In the present study, the final
68Ga
product contained 13% of colloidal forms of
68Ga.
Uncharged gallium hydroxide or gallium nanoparticles
are capable of penetrating the cell. Under the lower pH
conditions, inside the cell, the material ionizes and
becomes bound. Accordingly, accumulation into the
liver, spleen, and bone marrow would be expected
[12,13].
In blood,
68Ga-radioactivity can circulate also as a free
68Ga
3+ and mimic ferric ions. In spite of their physical
similarities, gallium and iron behave differently in vivo.
The major difference is the inability of gallium to be
reduced in vivo wherefore gallium remains bound to
iron-transport proteins and carrier molecules with the
inability to interact with protoporphyrin IX to form
heme. A high blood uptake of gallium is explained by its
binding to iron-binding molecules; transferrin, lactofer-
rin, and ferritin. One way to facilitate the solubilization
of
68Ga may be its chelation with citrate. For SPECT ima-
ging,
67Ga is indeed administrated as citrate to avoid pro-
tein binding. Since citrate is only a weak chelator in vivo,
67Ga is rapidly released, hydrolyzed, and bound to trans-
ferrin and other iron-binding proteins [12,14-16], sug-
gesting that chelation does not improve the uptake of the
tracer. We have compared uptakes of
68Ga and
68Ga-
citrate in rat osteomyelitis model (unpublished data), and
ascertained that there were no differences between
68Ga
and
68Ga-citrate uptakes in inflammation lesions.
In comparison to
67Ga-based SPECT,
68Ga-based PET
may have some advantages, such as a better resolution
for the detection of inflammation and a smaller radia-
tion exposure for the subject. However, the blood clear-
ance of
68Ga-radioactivity was slow as demonstrated by
ex vivo measurement and by in vivo PET/CT imaging.
Unfortunately, the relatively short half-life of
68Ga does
not allow delayed imaging times for better blood clear-
ance. In an inflamed lesion,
67Ga is accumulated in the
areas rich in infiltrated macrophages. Interestingly,
67Ga
is not accumulated at the sites of crowded neutrophils,
suggesting that the polymorphonuclear leukocytes do
not play a major role in the accumulation of
67Ga in
inflammatory lesions [17].
In the present study, the plaque/wall ratio of
68Ga was
1.8 ± 0.2. As compared to 2-deoxy-2-[
18F]fluoro-D-glu-
cose (
18F-FDG), we have measured the plaque/wall ratio
of 2.7 ± 1.1 approximately in the same aged LDLR
-/-
ApoB
100/100 mice as used in the present study [18]. It
has been shown that the clinical image qualities of
68Ga-tracers (b + decay 97%, Eb + max 0.64 MeV) and
18F-tracers (b + decay 97%, Eb + max 0.64 MeV) are
not necessarily very much different from each other
[19]. However,
68G ah a sah i g h e rk i n e t i ce n e r g yc o m -
pared to
18F, which could decrease the imaging spatial
resolution, particularly when a small plaque lesion is
imaged with a high resolution small PET/CT. Based on
these earlier observations,
18F-FDG seems to be more
promising PET tracer for imaging of atherosclerotic pla-
ques than
68Ga.
Clinical observations indicate that in normal circum-
stances, the major proportion of the gallium retained in
Figure 2 Uptake of
68Ga-radioactivity and the degree of
inflammation in atherosclerotic plaques. Uptake of
68Ga-
radioactivity in atherosclerotic plaques of LDLR
-/-ApoB
100/100 mice in
comparison to the degree of inflammation assessed on the basis of
Mac-3 immunohistochemistry. None, no macrophages; Mild,
occasional macrophages; Moderate, occasional and some groups of
macrophages; Severe, abundant infiltration of macrophages. The
68Ga-radioactivity uptake results are expressed as PSL/mm
2(mean ±
SD), normalized against internal control tissue (muscle).
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inflammatory lesions alter this biodistribution, fre-
quently causing decreased hepatic uptake [15]. In the
present study, a difference in the uptake of
68Ga
between the atherosclerotic mice and controls was
found in bone and liver. The uptake of
68Ga-radioactiv-
ity in the whole aorta of atherosclerotic mice was higher
than that in the control mice, but the difference was not
s i g n i f i c a n t .T h eu p t a k ei nt h ei n f l a m m a t o r yp l a q u e s
could partly explain the lower uptake of
68Ga in the
liver of atherosclerotic mice. More likely this may be
due to liver failure caused by high fat content, which
can occur in older LDLR
-/-ApoB
100/100 mice fed with a
Western-type diet. Concerning the uptake of
68Ga in the
bone, we assume that in the young control mice (aged
2.5 months), active bone remodeling may have
Figure 3 Mac-3 immunostained atherosclerotic plaques.( A) Representative Mac-3 immunostainings of severely inflamed plaque.
Macrophages are shown in brown color. Adventitia and healthy vessel wall areas were Mac-3 negative. (B) An enlarged area rich in
macrophages marked in (A). (C) Non-inflamed plaque with only scanty immunopositivity for Mac-3. L, lumen; P, plaque; W wall.
Figure 4 In vivo imaging. (A) In vivo PET, (B) CT angiography, and (C) fused PET/CT images demonstrate the high
68Ga signal in the blood pool
as seen in the aorta and heart. Calcified (white arrows) and non-calcified (black arrows), aortic arch and aortic root can be seen in contrast-
enhanced CT angiography.
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the older LDLR
-/-ApoB
100/100 mice (aged 10 to 11
months).
The accumulation of
68Ga-radioactivity in inflamma-
t o r yl e s i o n si sc o m p l e x ,a n dt h em a j o r i t yo f
68Ga is
probably delivered into the inflammatory lesions
through the increased permeability at the site of athero-
sclerotic arteries. In the present study, accumulated
68Ga-radioactivity was detected in the macrophages-rich
plaques suggesting that
68Ga accumulates at the site of
inflammation. In addition to that, calcified areas of
atherosclerotic plaques were also detected by
68Ga,
which may be explained by the competitive binding of
gallium ions to the Ca
2+ and Mg
2+ binding sites [17].
Since the calcified areas can be localized with CT, this
observation is not limiting the use of
68Ga to distinguish
macrophages-rich plaques and calcified plaques.
To some extent, gallium may also be taken up by
atherosclerotic plaques due to its binding to the circu-
lating transferrin and avidly to the transferrin receptors
at the site of atherosclerotic arteries. Transferrin recep-
tor expression has been shown to correlate positively
with macrophage infiltration in human carotid athero-
sclerotic lesions [20]. Moreover, symptomatic patients
with carotid atherosclerosis have significantly higher
expression of transferrin receptors than asymptomatic
patients [21]. However, although the uptake of
68Ga in
inflamed atherosclerotic plaques was promising as mea-
sured by autoradiography, the slow blood clearance lim-
its the use of ionic
68Ga for in vivo imaging of
atherosclerotic plaques.
Conclusions
Autoradiography analysis showed a moderate, but signif-
icantly higher
68Ga-radioactivity uptake in the aortic pla-
ques of atherosclerotic mice, especially at the sites rich
in macrophages, as compared to areas of healthy vessel
wall. While the uptake of
68Ga-radioactivity was promi-
nent in the atherosclerotic plaques of LDLR
-/-ApoB
100/
100 mice, the slow blood clearance limits the feasibility
of ionic
68Ga for clinical imaging of atherosclerotic pla-
ques especially in coronary arteries.
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